PMID- 16470700 OWN - NLM STAT- MEDLINE DCOM- 20060530 LR - 20231105 IS - 1552-4825 (Print) IS - 1552-4833 (Electronic) IS - 1552-4825 (Linking) VI - 140 IP - 6 DP - 2006 Mar 15 TI - A 9-year-old male with a duplication of chromosome 3p25.3p26.2: clinical report and gene expression analysis. PG - 573-9 AB - We describe a 9-year-old male referred for genetic evaluation for Prader-Willi syndrome (PWS). PWS is the most common genetically defined cause of life-threatening obesity and results from a functional loss of paternally expressed genes from the chromosome 15q11-q13 region. The patient presented with pervasive developmental disorder, delayed speech, and rapid onset of obesity at age 4 years, all features similar to PWS. However, chromosome 15q11-q13 methylation testing and fragile X studies were normal. GTG-banding and fluorescence in situ hybridization (FISH) with whole chromosome 3 paint probe (WCP3) and a chromosome 3p subtelomeric probe suggested a duplication of 3p25.3p26.2, a finding supported by comparative genomic hybridization (CGH). This region of chromosome 3p contains genes which contribute to obesity and behavioral problems, most notably, ghrelin (GHRL), an oxytocin receptor (OXTR), solute carrier family six members (gamma-aminobutyric acid (GABA) neurotransmitter transporters, SLC6A1 and SLC6A11), and peroxisome proliferator-activated receptor gamma (PPARG). To characterize these obesity and behavior related genes in our subject, we performed quantitative RT-PCR and compared expression levels with similarly aged male subjects (four non-obese males, four obese males, and four PWS males-two with 15q11-q13 deletions and two with maternal disomy 15). Our studies suggest increased expression of several genes in the 3p duplication region, including GHRL and PPARG, which may contribute to the phenotypic features in our 3p duplication subject. CI - 2006 Wiley-Liss, Inc. FAU - Bittel, Douglas C AU - Bittel DC AD - Children's Mercy Hospitals and Clinics, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri 64108, USA. FAU - Kibiryeva, Nataliya AU - Kibiryeva N FAU - Dasouki, Majed AU - Dasouki M FAU - Knoll, Joan H M AU - Knoll JH FAU - Butler, Merlin G AU - Butler MG LA - eng GR - R01 HD041672/HD/NICHD NIH HHS/United States GR - R01 HD041672-05/HD/NICHD NIH HHS/United States GR - R01HD41672/HD/NICHD NIH HHS/United States PT - Case Reports PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Am J Med Genet A JT - American journal of medical genetics. Part A JID - 101235741 RN - 0 (GABA Plasma Membrane Transport Proteins) RN - 0 (PPAR gamma) RN - 0 (SLC6A1 protein, human) RN - 0 (SLC6A11 protein, human) SB - IM MH - Child MH - *Chromosome Aberrations MH - Chromosome Banding MH - Chromosomes, Human, Pair 3/*genetics MH - GABA Plasma Membrane Transport Proteins/genetics MH - Gene Duplication MH - Gene Expression/genetics MH - Genome, Human MH - Humans MH - In Situ Hybridization, Fluorescence MH - Male MH - Nucleic Acid Hybridization/methods MH - PPAR gamma/genetics MH - Prader-Willi Syndrome/diagnosis/*genetics MH - Up-Regulation/genetics PMC - PMC2568077 MID - NIHMS68077 EDAT- 2006/02/14 09:00 MHDA- 2006/05/31 09:00 PMCR- 2008/10/16 CRDT- 2006/02/14 09:00 PHST- 2006/02/14 09:00 [pubmed] PHST- 2006/05/31 09:00 [medline] PHST- 2006/02/14 09:00 [entrez] PHST- 2008/10/16 00:00 [pmc-release] AID - 10.1002/ajmg.a.31132 [doi] PST - ppublish SO - Am J Med Genet A. 2006 Mar 15;140(6):573-9. doi: 10.1002/ajmg.a.31132.